Newly identified biomarker may predict NSCLC patients' treatment response to chemoimmunotherapy
Cutting-edge cancer treatments like immunotherapy are offering new hope for patients, often in combination with more common approaches such as chemotherapy. But determining the best treatment combination isn't always straightforward.